EGFR Levels and Prognosis in Laryngeal Cancer
Author Information
Author(s): M Maurizi, G Almadori, G Ferrandina, M Distefano, ME Romanini, G Cadoni, P Benedetti-Panici, G Paludetti, G Scambia, S Mancuso
Primary Institution: Catholic University, Rome, Italy
Hypothesis
High levels of epidermal growth factor receptor (EGFR) are associated with poor prognosis in laryngeal squamous cell carcinoma.
Conclusion
High EGFR levels are linked to a significantly worse prognosis in patients with laryngeal cancer.
Supporting Evidence
- Patients with EGFR- tumours had a 5-year survival rate of 81%, while those with EGFR+ tumours had a 25% survival rate.
- EGFR levels were directly associated with the risk of death and relapse.
- The cut-off value of 20 fmol mg-1 protein was the best prognostic discriminator.
Takeaway
If a patient has high levels of a certain protein called EGFR, they might not do as well with their laryngeal cancer compared to those with lower levels.
Methodology
EGFR content was measured in tissue samples from 140 laryngeal cancer patients using a radioligand receptor assay.
Limitations
The study was conducted at a single institution and may not be generalizable to all populations.
Participant Demographics
The study included 140 primary laryngeal cancer patients, predominantly male (130 males, 10 females).
Statistical Information
P-Value
0.0001
Confidence Interval
95% CI 74-88% for EGFR- tumours and 95% CI 5-45% for EGFR+ tumours.
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website